Australian Health Review Australian Health Review Society
Journal of the Australian Healthcare & Hospitals Association
RESEARCH ARTICLE

Reply to ‘Evidence-based review, not change in usage patterns, should drive Medicare Benefit Schedule (MBS) disinvestment decisions’

Linda Mundy

Queensland Health, Level 2, 15 Butterfield Street, Herston, Qld 4029, Australia. Email: linda.mundy@health.qld.gov.au

Australian Health Review - https://doi.org/10.1071/AH16239
Submitted: 24 October 2016  Accepted: 28 October 2016   Published online: 5 December 2016


References

[1]  Orchard JW, Orchard JJ, Damra DJ. Evidence-based review, not change in usage patterns, should drive Medicare Benefit Schedule (MBS) disinvestment decisions. Aust Health Rev 2016;
Evidence-based review, not change in usage patterns, should drive Medicare Benefit Schedule (MBS) disinvestment decisions.CrossRef | open url image1

[2]  Mundy L. Platelet-rich plasma: a case study for the identification of disinvestment opportunities using horizon scanning. Aust Health Rev 2016;
Platelet-rich plasma: a case study for the identification of disinvestment opportunities using horizon scanning.CrossRef | open url image1

[3]  Mundy L, Merlin TL, Parrella A, Babidge WJ, Roberts DE, Hiller JE. The Australia and New Zealand horizon scanning network. Aust Health Rev 2005; 29 395–7.
The Australia and New Zealand horizon scanning network.CrossRef | open url image1

[4]  Laudy AB, Bakker EW, Rekers M, Moen MH. Efficacy of platelet-rich plasma injections in osteoarthritis of the knee: a systematic review and meta-analysis. Br J Sports Med 2015; 49 657–72.
Efficacy of platelet-rich plasma injections in osteoarthritis of the knee: a systematic review and meta-analysis.CrossRef | open url image1

[5]  Medical Services Advisory Committee (MSAC). Intra-articular viscosupplementation for treatment of osteoarthritis of the knee. Canberra: MSAC; 2003. Available at: http://www.msac.gov.au/internet/msac/publishing.nsf/Content/6597E1FBFD707643CA25801000123B71/$File/1045-Assessment-Report.pdf [verified 8 July 2013].

[6]  Schmajuk G, Bozic KJ, Yazdany J. Using Medicare data to understand low-value health care: the case of intra-articular hyaluronic acid injections. JAMA 2014; 174 1702–4. open url image1

[7]  Patel S, Dhillon MS, Aggarwal S, Marwaha N, Jain A. Treatment with platelet-rich plasma is more effective than placebo for knee osteoarthritis: a prospective, double-blind, randomized trial. Am J Sports Med 2013; 41 356–64.
Treatment with platelet-rich plasma is more effective than placebo for knee osteoarthritis: a prospective, double-blind, randomized trial.CrossRef | open url image1



Export Citation